Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte precursor cell | 10 studies | 33% ± 13% | |
| adipocyte | 5 studies | 18% ± 3% | |
| astrocyte | 4 studies | 31% ± 14% | |
| endothelial cell | 3 studies | 25% ± 12% | |
| interneuron | 3 studies | 41% ± 13% | |
| glutamatergic neuron | 3 studies | 40% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 30% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 1360.13 | 2609 / 2642 | 100% | 24.33 | 702 / 705 |
| ovary | 100% | 3694.02 | 180 / 180 | 94% | 11.67 | 406 / 430 |
| skin | 96% | 1033.81 | 1731 / 1809 | 98% | 18.18 | 463 / 472 |
| adrenal gland | 100% | 1193.10 | 257 / 258 | 80% | 10.05 | 185 / 230 |
| pancreas | 91% | 538.36 | 299 / 328 | 84% | 6.13 | 149 / 178 |
| kidney | 91% | 752.49 | 81 / 89 | 78% | 4.33 | 704 / 901 |
| lung | 100% | 1763.42 | 576 / 578 | 66% | 3.67 | 765 / 1155 |
| breast | 100% | 1331.23 | 458 / 459 | 65% | 3.96 | 725 / 1118 |
| uterus | 99% | 1609.38 | 168 / 170 | 64% | 4.14 | 294 / 459 |
| thymus | 83% | 407.61 | 539 / 653 | 79% | 10.54 | 480 / 605 |
| esophagus | 80% | 582.14 | 1156 / 1445 | 79% | 5.31 | 144 / 183 |
| prostate | 98% | 1130.57 | 240 / 245 | 51% | 1.90 | 254 / 502 |
| stomach | 92% | 595.49 | 329 / 359 | 42% | 2.17 | 120 / 286 |
| liver | 65% | 331.04 | 148 / 226 | 56% | 4.31 | 226 / 406 |
| intestine | 86% | 773.34 | 831 / 966 | 31% | 1.79 | 164 / 527 |
| bladder | 86% | 459.71 | 18 / 21 | 28% | 1.23 | 142 / 504 |
| blood vessel | 100% | 1429.70 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1689.92 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 90% | 730.44 | 217 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 80% | 5.85 | 64 / 80 |
| heart | 77% | 399.74 | 660 / 861 | 0% | 0 | 0 / 0 |
| muscle | 70% | 341.14 | 564 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 69% | 3.32 | 31 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 21% | 0.85 | 6 / 29 |
| peripheral blood | 1% | 6.07 | 13 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0008584 | Biological process | male gonad development |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005813 | Cellular component | centrosome |
| GO_0016604 | Cellular component | nuclear body |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0003674 | Molecular function | molecular_function |
| Gene name | MAMLD1 |
| Protein name | Mastermind like domain containing 1 Alternative protein MAMLD1 Mastermind-like domain-containing protein 1 (F18) (Protein CG1) |
| Synonyms | CXorf6 CG1 |
| Description | FUNCTION: Transactivates the HES3 promoter independently of NOTCH proteins. HES3 is a non-canonical NOTCH target gene which lacks binding sites for RBPJ. . |
| Accessions | A0A804HJD4 ENST00000682016.1 ENST00000358892.7 ENST00000683453.1 ENST00000682253.1 [Q13495-1] A0A8C8KAR0 ENST00000370401.7 [Q13495-1] ENST00000262858.8 Q13495 ENST00000426613.5 [Q13495-4] A0A804HKM8 ENST00000432680.7 [Q13495-3] F8WAK3 L0R6K4 ENST00000683696.1 A0A804HJ96 |
